Zhejiang Huahai Pharmaceutical Co (SHSE:600521) Cyclically Adjusted Book per Share: ¥4.74 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600521 Zhejiang Huahai Pharmaceutical Co Ltd SHSE:600521
84 GF Score
Price ¥16.01
GF Value ¥16.46
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Zhejiang Huahai Pharmaceutical Co Cyclically Adjusted Book per Share?

Zhejiang Huahai Pharmaceutical Co SHSE:600521 -4.36% 84 Cyclically Adjusted Book per Share is ¥4.74 as of Mar. 2026. GuruFocus rates SHSE:600521 with a GF Score™ of 84/100 and a GF Value™ of ¥16.46 (Fairly Valued). The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Zhejiang Huahai Pharmaceutical Co's adjusted book value per share for the three months ended in Mar. 2026 was ¥6.577. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥4.74 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Zhejiang Huahai Pharmaceutical Co's average Cyclically Adjusted Book Growth Rate was 9.00% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 8.50% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 9.60% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 11.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Zhejiang Huahai Pharmaceutical Co was 16.90% per year. The lowest was 8.50% per year. And the median was 14.05% per year.

As of today (2026-07-26), Zhejiang Huahai Pharmaceutical Co's current stock price is ¥16.01. Zhejiang Huahai Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was ¥4.74. Zhejiang Huahai Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is 3.38.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Zhejiang Huahai Pharmaceutical Co was 16.42. The lowest was 2.93. And the median was 5.96.


Zhejiang Huahai Pharmaceutical Co  (SHSE:600521) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Zhejiang Huahai Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=16.01/4.74
=3.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Zhejiang Huahai Pharmaceutical Co was 16.42. The lowest was 2.93. And the median was 5.96.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Zhejiang Huahai Pharmaceutical Co Cyclically Adjusted Book per Share Related Terms


Zhejiang Huahai Pharmaceutical Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Zhejiang Huahai Pharmaceutical Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Huahai Pharmaceutical Co Cyclically Adjusted Book per Share Chart

Zhejiang Huahai Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.27 3.63 3.92 4.25 4.64

Zhejiang Huahai Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.35 4.43 4.54 4.64 4.74

SHSE:600521 vs ZTS, UTHR: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Huahai Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Huahai Pharmaceutical Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Huahai Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Zhejiang Huahai Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.


SHSE:600521
84GF Score
Zhejiang Huahai Pharmaceutical Co Ltd SHSE:600521
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhejiang Huahai Pharmaceutical Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Zhejiang Huahai Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=6.577/116.3033*116.3033
=6.577

Current CPI (Mar. 2026) = 116.3033.

Zhejiang Huahai Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201606 2.864 101.400 3.285
201609 2.932 102.400 3.330
201612 3.184 102.600 3.609
201703 3.294 103.200 3.712
201706 3.272 103.100 3.691
201709 3.414 104.100 3.814
201712 3.548 104.500 3.949
201803 3.667 105.300 4.050
201806 3.573 104.900 3.961
201809 3.620 106.600 3.950
201812 2.958 106.500 3.230
201903 3.053 107.700 3.297
201906 3.204 107.700 3.460
201909 3.820 109.800 4.046
201912 3.856 111.200 4.033
202003 4.010 112.300 4.153
202006 4.073 110.400 4.291
202009 4.250 111.700 4.425
202012 4.477 111.500 4.670
202103 4.649 112.662 4.799
202106 4.643 111.769 4.831
202109 4.557 112.215 4.723
202112 4.397 113.108 4.521
202203 4.490 114.335 4.567
202206 4.789 114.558 4.862
202209 4.788 115.339 4.828
202212 5.087 115.116 5.139
202303 5.214 115.116 5.268
202306 5.581 114.558 5.666
202309 5.448 115.339 5.494
202312 5.448 114.781 5.520
202403 5.612 115.227 5.664
202406 6.001 114.781 6.081
202409 5.995 115.785 6.022
202412 6.066 114.893 6.140
202503 6.485 115.116 6.552
202506 6.619 114.907 6.699
202509 6.352 115.471 6.398
202512 6.307 115.832 6.333
202603 6.577 116.303 6.577

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ¥4.74 mean?
Zhejiang Huahai Pharmaceutical Co (SHSE:600521) has a Cyclically Adjusted Book per Share of ¥4.74 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Zhejiang Huahai Pharmaceutical Co and its competitors.
Is Zhejiang Huahai Pharmaceutical Co's Cyclically Adjusted Book per Share too high?
Zhejiang Huahai Pharmaceutical Co's current Cyclically Adjusted Book per Share is ¥4.74. Overall, Zhejiang Huahai Pharmaceutical Co has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Huahai Pharmaceutical Co's Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Zhejiang Huahai Pharmaceutical Co's Cyclically Adjusted Book per Share of ¥4.74 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Zhejiang Huahai Pharmaceutical Co and its competitors. Zhejiang Huahai Pharmaceutical Co's current Cyclically Adjusted Book per Share is ¥4.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Huahai Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Huahai Pharmaceutical Co (SHSE:600521) is currently considered Fairly Valued. The stock's GF Value™ is ¥16.46, compared to a current price of ¥16.01 — trading 2.7% below its estimated fair value. The current Cyclically Adjusted Book per Share is ¥4.74. Zhejiang Huahai Pharmaceutical Co's overall GF Score™ is 84/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Zhejiang Huahai Pharmaceutical Co (SHSE:600521), the current Cyclically Adjusted Book per Share is ¥4.74 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zhejiang Huahai Pharmaceutical Co (SHSE:600521) Overvalued in 2026?

Based on GuruFocus' analysis, Zhejiang Huahai Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥16.01 is trading 2.7% below its estimated GF Value™ of ¥16.46. GuruFocus considers Zhejiang Huahai Pharmaceutical Co to be Fairly Valued.

Key valuation signals for SHSE:600521:

  • Cyclically Adjusted Book per Share: ¥4.74
  • GF Value™: ¥16.46 vs. price of ¥16.01 (2.7% below fair value)
  • GF Score™: 84/100 with 8 warning signs

No single metric tells the full story. See the SHSE:600521 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Zhejiang Huahai Pharmaceutical Co Business Description

Address Xunqiao, Zhejiang Province, Linhai, CHN, 317024
Zhejiang Huahai Pharmaceutical Co Ltd is engaged in research and development, production, and sales of multi-dosage preparations, biological drugs, innovative drugs, and specialty APIs. The company's products include irbesartan hydrochlorothiazide tablets, losartan potassium tablets, paroxetine hydrochloride tablets, sertraline hydrochloride tablets, linagliptin tablets, dabigatran etexilate capsules, pemetrexed disodium for injection, esomeprazole magnesium enteric-coated capsules, torsemide injection, and others.
84GF Score

Get the complete analysis for SHSE:600521

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥16.01
Price
¥16.46
GF Value